Nicholas Quinn

2PUBLICATIONS
22CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 03, 2024
Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.

Glenn J Hanna, L B Oakley, R Shi

|Jun 16, 2021
Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors.

Khanh T Do, Bose Kochupurakkal, Sarah Kelland

Pageof 1